Variables | Adjusted OR | 95%CI | P* |
---|---|---|---|
Sociodemographic level (Model 1) | |||
Female (Ref.: Male) | 1.713 | 1.270–2.311 | < 0.001 |
Age, years (Ref.: < 19) | |||
19 up to < 30 | 2.063 | 1.233–3.53 | 0.006 |
≥ 30 to < 40 | 2.368 | 1.349–4.158 | 0.003 |
≥ 40 | 3.534 | 1.953–6.394 | < 0.001 |
Self-reported skin-color (Ref.: Black) | |||
White | 4.188 | 2.077–8.444 | < 0.001 |
Brown | 3.018 | 1.474–6.178 | 0.003 |
Level of care (Ref.: Secondary) | |||
Tertiary | 1.141 | 0.741–1.757 | 0.548 |
Diabetes duration, years | 1.018 | 1.000–1.036 | 0.047 |
Time of follow up, years | 0.996 | 0.976–1.016 | 0.662 |
Geographic region (Ref. Mid-West) | |||
Southeast | 1.071 | 0.596–1.925 | 0.818 |
South | 1.076 | 0.537–2.156 | 0837 |
North/Northeast | 0.494 | 0.288–0.849 | 0.01 |
Economic status (Ref. High) | |||
Medium | 0.803 | 0.359–1.798 | 0.594 |
Low | 0.678 | 0.301–1.523 | 0.346 |
Very low | 0.464 | 0.117–1.838 | 0.274 |
Laboratorial data (Model 2) | |||
C-reactive protein (mg/dl) | 0.914 | 0.779–1.073 | 0.545 |
Anti-TPO UI/ml** (Ref. < 35) | |||
≥ 35 | 7.703 | 5.756–10.309 | < 0.001 |